Ramu A, Chinnappan J
Microrna. 2024; 13(1):33-55.
PMID: 38284737
DOI: 10.2174/0122115366253242231020053221.
Maharati A, Tolue Ghasaban F, Akhlaghipour I, Taghehchian N, Zangouei A, Moghbeli M
J Mol Histol. 2023; 54(6):559-578.
PMID: 37759132
DOI: 10.1007/s10735-023-10159-0.
Ferreira Alves L, Geraldo M
Front Oncol. 2023; 13:1039654.
PMID: 36776296
PMC: 9911110.
DOI: 10.3389/fonc.2023.1039654.
Alkhathami A, Verma A, Alfaifi M, Kumar L, Yahya Alshahrani M, Hakami A
J Oncol. 2021; 2021:9657071.
PMID: 34659414
PMC: 8519670.
DOI: 10.1155/2021/9657071.
Poursaleh A, Beigee F, Esfandiari G, Najafi M
BMC Cardiovasc Disord. 2021; 21(1):395.
PMID: 34399692
PMC: 8369609.
DOI: 10.1186/s12872-021-02203-2.
Long non‑coding RNA SNHG20 promotes colorectal cancer cell proliferation, migration and invasion via miR‑495/STAT3 axis.
Wang Y, Fu J, Yang L, Liang Z
Mol Med Rep. 2020; 23(1).
PMID: 33179110
PMC: 7705999.
DOI: 10.3892/mmr.2020.11669.
Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
Du C, Lv C, Feng Y, Yu S
J Exp Clin Cancer Res. 2020; 39(1):223.
PMID: 33087165
PMC: 7576758.
DOI: 10.1186/s13046-020-01735-3.
Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p.
Chen F, Liu L, Wang S
Cancer Cell Int. 2020; 20:323.
PMID: 32694945
PMC: 7368683.
DOI: 10.1186/s12935-020-01371-z.
Detection of Extracellular Vesicle RNA Using Molecular Beacons.
de Oliveira Jr G, Zigon E, Rogers G, Davodian D, Lu S, Jovanovic-Talisman T
iScience. 2020; 23(1):100782.
PMID: 31958756
PMC: 6992906.
DOI: 10.1016/j.isci.2019.100782.
Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
Luo S, Liao X, Zhu X
J Cancer. 2019; 10(25):6298-6313.
PMID: 31772663
PMC: 6856753.
DOI: 10.7150/jca.33250.
Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility.
Kim E, Kim J, Park H, Ryu C, Oh J, Jun H
BMC Cancer. 2019; 19(1):480.
PMID: 31117970
PMC: 6532172.
DOI: 10.1186/s12885-019-5641-1.
miRNA-766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4.
Chen W, Cai G, Liao Z, Lin K, Li G, Li Y
Exp Ther Med. 2019; 17(5):4100-4108.
PMID: 31007746
PMC: 6468453.
DOI: 10.3892/etm.2019.7436.
MicroRNA‑25/ATXN3 interaction regulates human colon cancer cell growth and migration.
Li D, Zhang T, Lai J, Zhang J, Wang T, Ling Y
Mol Med Rep. 2019; 19(5):4213-4221.
PMID: 30942397
PMC: 6471560.
DOI: 10.3892/mmr.2019.10090.
Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.
Li J, Shen H, Xie H, Ying Y, Jin K, Yan H
Cancer Manag Res. 2019; 11:777-787.
PMID: 30697070
PMC: 6339654.
DOI: 10.2147/CMAR.S190764.
MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.
Ye Y, Zhuang J, Wang G, He S, Zhang S, Wang G
Exp Ther Med. 2018; 15(1):1150-1158.
PMID: 29434703
PMC: 5772956.
DOI: 10.3892/etm.2017.5467.
MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.
Liu Y, Wang M, Luo Y, Chen J, Lu Y, Shi Y
Sci Rep. 2017; 7(1):11054.
PMID: 28887510
PMC: 5591282.
DOI: 10.1038/s41598-017-11351-5.
miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
Zou Z, Zou R, Zong D, Shi Y, Chen J, Huang J
J Cell Mol Med. 2017; 21(9):1929-1943.
PMID: 28411377
PMC: 5571520.
DOI: 10.1111/jcmm.13114.
Targeting MicroRNAs in Cancer Gene Therapy.
Ji W, Sun B, Su C
Genes (Basel). 2017; 8(1).
PMID: 28075356
PMC: 5295016.
DOI: 10.3390/genes8010021.